Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

DDR Gene Mutation: early-phase trial registry

1 of 1 indexed DDR Gene Mutation trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

DDR Gene Mutation: 1 US clinical trial tracked, 1 recruiting.

DDR Gene Mutation is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Lantern Pharma, running 1 of these trials.

Enrollment posture brief

Registry condition ddr-gene-mutation

OPEN 1 | RECR 100% | LATE 0 | EARLY 1 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

DDR Gene Mutation (this)100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near DDR Gene Mutation

DDR Gene Mutation lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for DDR Gene Mutation on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. DDR Gene Mutation is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 11

Phase Distribution

PhaseTrial count
Phase 1 1

Top Sponsors

Lantern Pharma 1 trials

Named interventions

Most-linked intervention names on DDR Gene Mutation records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

LP-184 Drug
1 trials
Spironolactone Drug
1 trials
Olaparib Drug
1 trials

US sites by state

Facility locations filed on DDR Gene Mutation trials. A trial with sites in several states counts in each.

Utah 1 trials
Texas 1 trials
Pennsylvania 1 trials
Maryland 1 trials
Kentucky 1 trials
Indiana 1 trials
Illinois 1 trials
California 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this DDR Gene Mutation page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 DDR Gene Mutation trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Lantern Pharma sponsors the most DDR Gene Mutation trials on record, review their full trial history before evaluating a specific study. See Lantern Pharma's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This DDR Gene Mutation condition card totals 1 registered trials; most-linked intervention LP-184; top US site state Utah. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.